Loading stock data...

Dr. Lal PathLabs Limited

NSE: LALPATHLAB BSE: LALPATHLAB

NSE
3,135.50 46.10 (1.49%)

Prev Close

3089.4

Open Price

3089.9

Volume

528,275

Today Low / High

3063 / 3208.9

52 WK Low / High

2293.55 / 3540

Range

2,979 - 3,292

BSE
3,137.05 48.05 (1.56%)

Prev Close

3089

Open Price

3072.35

Volume

13,997

Today Low / High

3064 / 3210.2

52 WK Low / High

2295.1 / 3542.6

Range

2,980 - 3,294

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 3135.5 (target range: 2,979 - 3,292), reflecting a change of 46.1 (1.4922%). On the BSE, it is listed at 3137.05 (target range: 2,980 - 3,294), showing a change of 48.05 (1.55552%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.

30 Oct 3,083.00 0.21%
29 Oct 3,111.90 -0.72%
28 Oct 3,160.00 -2.16%
27 Oct 3,100.00 1.42%
24 Oct 3,072.30 -0.78%
23 Oct 3,116.00 -1.42%
21 Oct 3,147.30 -0.35%
20 Oct 3,108.10 1.26%
17 Oct 3,157.50 -1.56%
16 Oct 3,106.00 1.63%
15 Oct 3,200.60 -2.44%
14 Oct 3,220.00 -1.36%
13 Oct 3,100.00 3.98%
10 Oct 3,063.00 1.10%
09 Oct 3,061.00 0.89%
08 Oct 3,146.60 -2.13%
07 Oct 3,190.90 -1.39%
06 Oct 3,127.70 1.66%
03 Oct 3,151.00 -0.74%

Dr. Lal PathLabs Limited Graph

Dr. Lal PathLabs Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Dr. Lal PathLabs Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 3,135.50, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 3,137.05 3,168.42 2,851.58 - 3,485.26
3,199.79 2,559.83 - 3,839.75
3,231.16 2,261.81 - 4,200.51
Bearish Scenario 3,137.05 3,105.68 2,795.11 - 3,416.25
3,074.31 2,459.45 - 3,689.17
3,042.94 2,130.06 - 3,955.82

Overview of Dr. Lal PathLabs Limited

ISIN

INE600L01024

Industry

Medical - Diagnostics & Research

Vol.Avg

130,308

Market Cap

257,863,268,008

Last Dividend

24

Official Website

Visit Website

IPO Date

2015-12-23

DCF Diff

-6,457.69

DCF

9,766

Financial Ratios Every Investor Needs

Stock Dividend of LALPATHLAB

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-08-06 August 06, 25 6 6 2025-08-06 2025-08-30
2025-06-06 June 06, 25 6 6 2025-06-06 2025-07-27
2025-02-05 February 05, 25 6 6 2025-02-05 2025-03-01
2024-11-05 November 05, 24 6 6 2024-11-05 2024-11-22
2024-08-20 August 20, 24 6 6 2024-08-20 2024-09-06

Stock Rating Details for LALPATHLAB

Metric Value Recommendation
Overall Rating B- Sell
DCF Score 5 Strong Buy
ROE Score 5 Strong Buy
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 2,461.40 Cr 1,037.29 Cr 1,424.11 Cr 0.5786 0.00 Cr 341.66 Cr 972.89 Cr 487.14 Cr 58.48 657.93 Cr 0.1979
2024-03-31 2,226.64 Cr 947.61 Cr 1,279.03 Cr 0.5744 0.00 Cr 313.01 Cr 864.51 Cr 357.74 Cr 43.05 567.26 Cr 0.1607
2023-03-31 2,016.88 Cr 891.96 Cr 1,124.92 Cr 0.5578 0.00 Cr 282.03 Cr 767.21 Cr 238.85 Cr 28.82 441.23 Cr 0.1184
2022-03-31 2,087.41 Cr 919.76 Cr 1,167.65 Cr 0.5594 0.00 Cr 284.54 Cr 819.67 Cr 344.83 Cr 41.70 518.85 Cr 0.1652
2021-03-31 1,581.27 Cr 704.75 Cr 876.52 Cr 0.5543 0.00 Cr 204.28 Cr 626.44 Cr 291.62 Cr 35.33 398.87 Cr 0.1844

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 292.63 Cr 2,716.80 Cr 510.30 Cr 2,172.7000 Cr 157.40 Cr -681.30 Cr 36.10 Cr 342.66 Cr 0.00 Cr 0.00 Cr 97.37 Cr 402.5000 Cr
2024-03-31 360.93 Cr 2,455.96 Cr 570.60 Cr 1,849.2830 Cr 246.93 Cr -114.00 Cr 37.31 Cr 346.98 Cr 22.48 Cr 0.00 Cr 65.40 Cr 465.1880 Cr
2023-03-31 263.70 Cr 2,385.50 Cr 686.00 Cr 1,666.3000 Cr 419.50 Cr 155.80 Cr 33.80 Cr 404.00 Cr 75.90 Cr 0.00 Cr -547.20 Cr 469.8000 Cr
2022-03-31 378.20 Cr 2,353.22 Cr 809.68 Cr 1,508.0770 Cr 532.44 Cr 154.24 Cr 52.54 Cr 444.85 Cr 91.10 Cr 0.00 Cr 7.10 Cr 499.9880 Cr
2021-03-31 244.30 Cr 1,661.33 Cr 385.32 Cr 1,245.0590 Cr 150.37 Cr -93.93 Cr 42.56 Cr 317.62 Cr 18.04 Cr 0.24 Cr -735.75 Cr 274.2850 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 568.8000 Cr -303.1000 Cr -334.0000 Cr 524.5000 Cr -68.3330 Cr 292.6000 Cr -44.3000 Cr 487.1000 Cr -83.3340 Cr -207.3000 Cr 1.1750 Cr
2024-03-31 535.3340 Cr -24.2690 Cr -413.8630 Cr 484.1670 Cr 97.2020 Cr 360.9330 Cr -51.1670 Cr 357.7350 Cr -153.3370 Cr -201.1690 Cr -3.5000 Cr
2023-03-31 456.0000 Cr -287.3000 Cr -283.2000 Cr 411.4000 Cr -114.5000 Cr 263.7000 Cr -44.6000 Cr 241.1000 Cr -143.1760 Cr -103.0130 Cr 18.7000 Cr
2022-03-31 446.6940 Cr -449.2470 Cr 136.4510 Cr -29.4490 Cr 133.8970 Cr 378.1950 Cr -476.1430 Cr 350.2910 Cr 345.4000 Cr -116.6600 Cr -9.9830 Cr
2021-03-31 398.1500 Cr -212.0160 Cr -138.5560 Cr 338.5600 Cr 47.5780 Cr 244.2980 Cr -59.5900 Cr 296.4790 Cr -23.5270 Cr -99.4830 Cr 14.4020 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 669.80 Cr 261.20 Cr 408.60 Cr 0.6100 316.40 Cr 132.40 Cr 15.88 182.36 Cr 0.1977
2025-03-31 602.60 Cr 306.59 Cr 296.01 Cr 0.4912 108.89 Cr 154.84 Cr 18.57 162.96 Cr 0.2570
2024-12-31 596.70 Cr 243.40 Cr 353.30 Cr 0.5921 266.60 Cr 96.70 Cr 11.60 143.28 Cr 0.1621
2024-09-30 660.20 Cr 251.30 Cr 408.90 Cr 0.6194 315.20 Cr 129.20 Cr 15.52 202.20 Cr 0.1957
2024-06-30 601.90 Cr 236.00 Cr 365.90 Cr 0.6079 282.20 Cr 106.40 Cr 12.79 160.08 Cr 0.1768

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-06-30 0.00 Cr 0.00 Cr 1,164.07 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -2,206.48 Cr
2025-03-31 292.63 Cr 871.45 Cr 1,165.40 Cr 123.83 Cr 36.10 Cr 1,363.50 Cr 342.66 Cr 2,716.80 Cr 510.30 Cr
2024-12-31 0.00 Cr 0.00 Cr 1,126.70 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -2,035.20 Cr
2024-09-30 838.00 Cr 288.70 Cr 1,126.70 Cr 91.10 Cr 46.80 Cr 1,325.60 Cr 329.10 Cr 2,597.50 Cr 562.30 Cr
2024-06-30 -942.60 Cr 1,885.19 Cr 942.60 Cr 0.00 Cr 0.00 Cr 942.60 Cr 0.00 Cr 0.00 Cr -1,885.36 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 132.40 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 154.80 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 96.70 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 129.20 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 106.40 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Diagnostics & Research

Company Name Symbol Price Market Cap Volume
Dr. Lal PathLabs Limited LALPATHLAB ₹3,135.50 ₹261,711,101,457.00 ₹528,275.00
Sai Life Sciences Ltd. SAILIFE ₹918.20 ₹192,750,189,414.00 ₹306,490.00
Metropolis Healthcare Limited METROPOLIS ₹1,970.40 ₹102,067,064,820.00 ₹36,140.00
Vijaya Diagnostic Centre Limited VIJAYA ₹988.65 ₹101,559,007,976.00 ₹105,020.00
Thyrocare Technologies Limited THYROCARE ₹1,397.30 ₹74,131,989,505.00 ₹362,103.00
Vimta Labs Limited VIMTALABS ₹725.40 ₹32,279,866,211.00 ₹539,210.00

Key Executives

Chief Executive Officer
Mr. Shankha Banerjee

Gender: male

Year Born:

Chief Operating Officer
Mr. Jai Prakash Meena

Gender: male

Year Born:

Group Chief Financial Officer & Chief Executive Officer of International Business
Mr. Ved Prakash Goel C.A.

Gender: male

Year Born:

Group Chief Human Resources Officer
Mr. Manoj Kumar Garg

Gender: male

Year Born: 1969

Executive Director
Dr. Vandana Lal

Gender: Not Specified

Year Born: 1956

Company Secretary & Compliance Officer
Mr. Vinay Gujral

Gender: male

Year Born:

Executive Chairman
Brigadier Arvind Lal

Gender: Not Specified

Year Born: 1949

Chief Information & Digital Officer
Mr. Munender Soperna

Gender: male

Year Born:

FAQs about Dr. Lal PathLabs Limited

Who is the CEO of the company?

The CEO is Shankha Banerjee.

What is the current market price of the stock?

The current price is ₹3,089.40.

What is the 52-week price range?

The range is ₹2293.55-3540.

What is the market capitalization of the company?

The market capitalization is ₹25,786.33 crores.

What is the dividend yield?

The dividend yield is 0.78%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 50.20.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Dr. Lal PathLabs Limited (ISIN: INE600L01024) is a leading Medical - Diagnostics & Research in India. With a market capitalization of ₹25,786.33 crores and an average daily volume of 130,308 shares, it operates in the Medical - Diagnostics & Research. The company last declared a dividend of ₹24.